Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Vaccine Scheduling Update:
We’re experiencing very high call volumes from people interested in getting the COVID-19 vaccine. Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.
Dr. Dokras discusses preimplantation genetic testing, as well as preimplantation genetic screening, at Penn Fertility Care.
Preimplantation genetic testing (PGT) is a screening test used to determine if genetic or chromosomal disorders are present in embryos produced through in vitro fertilization (IVF). PGT screens embryos before they are transferred to the uterus so couples can make informed decisions about their next steps in the IVF process. Embryos unaffected by the genetic or chromosomal disorder can be selected for transfer to the uterus.
For couples undergoing IVF, PGT may be recommended when:
Thousands of clinical PGT cycles have been performed worldwide, resulting in the birth of hundreds of healthy babies.
PGT does not replace prenatal testing, such as chorionic villus sampling or amniocentesis. It provides diagnostic information based on the analysis of a single cell, so prenatal testing is still recommended and currently remains the standard of care.
Learn the step-by-step process for identifying genetic or chromosomal disorders in embryos via preimplantation genetic diagnosis.